Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy of HSP90 inhibitors and PD-1 inhibitors for treating cancer

Combination therapy of HSP90 inhibitors and PD-1 inhibitors for treating cancer

US Patent 11497733 · Granted Nov 15, 2022

Estimated economic value: $17,820,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapies comprising targeted therapeutics2022
Methods of using anti-lap antibodies2022
Combination therapy for treatment of ovarian cancer2021
Anti-lap antibody variants2021
Combination therapy of HSP90 inhibitors with platinum-containing agents2019
Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhi2016
Combination therapy of HSP90 inhibitors with BRAF inhibitors2016
Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR in2015
Treating cancer with HSP90 inhibitory compounds2014
ILT3 binding molecules and uses therefor2014
Use of bis [thiohydrazide amide] compounds such as elesclomol for treating canc2014
Compositions and methods of tolerizing a primate to an antigen2011